Effect of Increasing Dietary Fiber on Plasma Levels of Colon-Derived Solutes in Hemodialysis Patients
2014; Lippincott Williams & Wilkins; Volume: 9; Issue: 9 Linguagem: Inglês
10.2215/cjn.00490114
ISSN1555-905X
AutoresTammy L. Sirich, Natalie S. Plummer, Christopher D. Gardner, Thomas H. Hostetter, Timothy W. Meyer,
Tópico(s)Renal function and acid-base balance
ResumoBackground and objectives Numerous uremic solutes are derived from the action of colon microbes. Two such solutes, indoxyl sulfate and p-cresol sulfate, have been associated with adverse outcomes in renal failure. This study tested whether increasing dietary fiber in the form of resistant starch would lower the plasma levels of these solutes in patients on hemodialysis. Design, setting, participants, & measurements Fifty-six patients on maintenance hemodialysis were randomly assigned to receive supplements containing resistant starch (n=28) or control starch (n=28) daily for 6 weeks in a study conducted between October 2010 and May 2013. Of these, 40 patients (20 in each group) completed the study and were included in the final analysis. Plasma indoxyl sulfate and p-cresol sulfate levels were measured at baseline and week 6. Results Increasing dietary fiber for 6 weeks significantly reduced the unbound, free plasma level of indoxyl sulfate (median −29% [25th percentile, 75th percentile, −56, −12] for fiber versus −0.4% [−20, 34] for control, P=0.02). The reduction in free plasma levels of indoxyl sulfate was accompanied by a reduction in free plasma levels of p-cresol sulfate (r=0.81, P<0.001). However, the reduction of p-cresol sulfate levels was of lesser magnitude and did not achieve significance (median −28% [−46, 5] for fiber versus 4% [−28, 36] for control, P=0.05). Conclusions Increasing dietary fiber in hemodialysis patients may reduce the plasma levels of the colon-derived solutes indoxyl sulfate and possibly p-cresol sulfate without the need to intensify dialysis treatments. Further studies are required to determine whether such reduction provides clinical benefits.
Referência(s)